Product Overview
Labetuzumab govitecan | T25593 | TargetMol Chemicals
CAS: 1469876-18-3
Smiles: CCc1c2Cn3c(cc4c(COC(=O)[C@@]4(CC)OC(=O)OCc4ccc(NC(=O)[C@H](CCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCn5cc(CNC(=O)C6CCC(CN7C(=O)CC(SC[C@H](N)C(O)=O)C7=O)CC6)nn5)cc4)c3=O)-c2nc2ccc(O)cc12
Formula: C75H102N12O24S
Pathway: N/A
Target: N/A
Receptor: N/A
Bioactivity: Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer.
Molecular Weight: 1587, 76